Thanks to research, many changes have happened in the treatment of myeloma. This conference will offer you the opportunity to learn the newest information available. Learn, share and get the answers to your questions!

The keynote luncheon speaker is Douglas Emerson, whose advocacy actions on behalf of his father, inspired our campaign for Velcade funding. Today Velcade is an important treatment option in our myeloma ‘treatment toolbox’. You will find his message both interesting and inspiring.

Other presenters include:

* Dr. Chris Chen Assistant Professor, University of Toronto, Education Coordinator, Myeloma Group, Princess Margaret Hospital
* Dr. Anargyros Xenocostas Consultant, Hematology, Department of Medicine, London Health Sciences Centre, Assistant Professor, Department of Medicine, University of Western Ontario
* Dr. Donna E. Reece, Director, Program for Multiple Myeloma & Related Diseases, Princess Margaret Hospital, Toronto
* Chris Polci Patient Relations Specialist, London Health Sciences Centre
* Carlo De Angelis Clinical Pharmacy Coordinator, Oncology, Odette Cancer Centre, Assistant Professor, Faculty of Pharmacy, University of Toronto

The last presentation of the day is Pharmacist, London Regional Cancer Program, The Road to Accessing Drug Treatments.

For registration and information please call:
Education, London Regional Cancer Program - (519) 685-8742
OR visit the website http://www.myelomacanada.ca/en/ontario.htm#london

   Email me new posts to this topic.